Immunomodulatory cationic peptide therapeutics: A new paradigm in infection and immunity

Neeloffer Mookherjee, Leola N.Y. Chow, Robert Hancock

Research output: Chapter in Book/Report/Conference proceedingConference contribution

2 Citations (Scopus)

Abstract

Natural cationic host defence (antimicrobial) peptides are widely distributed gene encoded molecules with diverse structures. There are more than 1200 natural Host Defence Peptides (HDPs) described to date. Due to the multifunctional roles defined for such peptides there is a keen interest in the potential therapeutic applications of HDPs and their synthetic mimics, Antimicrobial peptides and Innate Defence Regulator (IDR) peptides. These peptides constitute two broad classes of potential therapeutics; (i) with direct antimicrobial and/or anti-biofilm activity, and (ii) with immune-modulating and/or anti-inflammatory activity. Exploiting the immunomodulatory functions of these peptides represents a new therapeutic approach for resolution of infections and inflammatory disorders.

LanguageEnglish
Title of host publicationSmall Wonders
Subtitle of host publicationPeptides for Disease Control
PublisherAmerican Chemical Society
Pages1-19
Number of pages19
ISBN (Print)9780841227484
DOIs
Publication statusPublished - 1 Jan 2012

Publication series

NameACS Symposium Series
Volume1095
ISSN (Print)0097-6156
ISSN (Electronic)1947-5918

ASJC Scopus subject areas

  • Chemistry(all)
  • Chemical Engineering(all)

Cite this

Mookherjee, N., Chow, L. N. Y., & Hancock, R. (2012). Immunomodulatory cationic peptide therapeutics: A new paradigm in infection and immunity. In Small Wonders: Peptides for Disease Control (pp. 1-19). (ACS Symposium Series; Vol. 1095). American Chemical Society. https://doi.org/10.1021/bk-2012-1095.ch001
Mookherjee, Neeloffer ; Chow, Leola N.Y. ; Hancock, Robert. / Immunomodulatory cationic peptide therapeutics : A new paradigm in infection and immunity. Small Wonders: Peptides for Disease Control. American Chemical Society, 2012. pp. 1-19 (ACS Symposium Series).
@inproceedings{994c9dbe75404c4dadf4a0298a8b324e,
title = "Immunomodulatory cationic peptide therapeutics: A new paradigm in infection and immunity",
abstract = "Natural cationic host defence (antimicrobial) peptides are widely distributed gene encoded molecules with diverse structures. There are more than 1200 natural Host Defence Peptides (HDPs) described to date. Due to the multifunctional roles defined for such peptides there is a keen interest in the potential therapeutic applications of HDPs and their synthetic mimics, Antimicrobial peptides and Innate Defence Regulator (IDR) peptides. These peptides constitute two broad classes of potential therapeutics; (i) with direct antimicrobial and/or anti-biofilm activity, and (ii) with immune-modulating and/or anti-inflammatory activity. Exploiting the immunomodulatory functions of these peptides represents a new therapeutic approach for resolution of infections and inflammatory disorders.",
author = "Neeloffer Mookherjee and Chow, {Leola N.Y.} and Robert Hancock",
year = "2012",
month = "1",
day = "1",
doi = "10.1021/bk-2012-1095.ch001",
language = "English",
isbn = "9780841227484",
series = "ACS Symposium Series",
publisher = "American Chemical Society",
pages = "1--19",
booktitle = "Small Wonders",
address = "United States",

}

Mookherjee, N, Chow, LNY & Hancock, R 2012, Immunomodulatory cationic peptide therapeutics: A new paradigm in infection and immunity. in Small Wonders: Peptides for Disease Control. ACS Symposium Series, vol. 1095, American Chemical Society, pp. 1-19. https://doi.org/10.1021/bk-2012-1095.ch001

Immunomodulatory cationic peptide therapeutics : A new paradigm in infection and immunity. / Mookherjee, Neeloffer; Chow, Leola N.Y.; Hancock, Robert.

Small Wonders: Peptides for Disease Control. American Chemical Society, 2012. p. 1-19 (ACS Symposium Series; Vol. 1095).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

TY - GEN

T1 - Immunomodulatory cationic peptide therapeutics

T2 - A new paradigm in infection and immunity

AU - Mookherjee, Neeloffer

AU - Chow, Leola N.Y.

AU - Hancock, Robert

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Natural cationic host defence (antimicrobial) peptides are widely distributed gene encoded molecules with diverse structures. There are more than 1200 natural Host Defence Peptides (HDPs) described to date. Due to the multifunctional roles defined for such peptides there is a keen interest in the potential therapeutic applications of HDPs and their synthetic mimics, Antimicrobial peptides and Innate Defence Regulator (IDR) peptides. These peptides constitute two broad classes of potential therapeutics; (i) with direct antimicrobial and/or anti-biofilm activity, and (ii) with immune-modulating and/or anti-inflammatory activity. Exploiting the immunomodulatory functions of these peptides represents a new therapeutic approach for resolution of infections and inflammatory disorders.

AB - Natural cationic host defence (antimicrobial) peptides are widely distributed gene encoded molecules with diverse structures. There are more than 1200 natural Host Defence Peptides (HDPs) described to date. Due to the multifunctional roles defined for such peptides there is a keen interest in the potential therapeutic applications of HDPs and their synthetic mimics, Antimicrobial peptides and Innate Defence Regulator (IDR) peptides. These peptides constitute two broad classes of potential therapeutics; (i) with direct antimicrobial and/or anti-biofilm activity, and (ii) with immune-modulating and/or anti-inflammatory activity. Exploiting the immunomodulatory functions of these peptides represents a new therapeutic approach for resolution of infections and inflammatory disorders.

UR - http://www.scopus.com/inward/record.url?scp=84905572998&partnerID=8YFLogxK

U2 - 10.1021/bk-2012-1095.ch001

DO - 10.1021/bk-2012-1095.ch001

M3 - Conference contribution

SN - 9780841227484

T3 - ACS Symposium Series

SP - 1

EP - 19

BT - Small Wonders

PB - American Chemical Society

ER -

Mookherjee N, Chow LNY, Hancock R. Immunomodulatory cationic peptide therapeutics: A new paradigm in infection and immunity. In Small Wonders: Peptides for Disease Control. American Chemical Society. 2012. p. 1-19. (ACS Symposium Series). https://doi.org/10.1021/bk-2012-1095.ch001